Objectives: Tracheostomy is indicated for very-low-birth-weight infants (VLBWIs) with prolonged respiratory problems during the perinatal period. The objective of this study is to clarify the epidemiology and risk factors in VLBWIs with tracheostomy after birth in Japan.
| INTRODUCTION
Recent advances in perinatal-neonatal medicine have greatly reduced the mortality and morbidity of very-low-birth-weight infants (VLBWIs; weighing less than 1500 g at birth). 1, 2 In the last two decades, a variety of therapeutic modalities for respiratory disturbances have been introduced in neonatal intensive care including surfactant treatment, 3 postnatal steroid therapy, 4, 5 and mechanical ventilation techniques 6, 7 in neonatal intensive care units (NICUs).
Tracheostomy is generally indicated for infants who require prolonged mechanical ventilation due to chronic respiratory insufficiency, congenital or acquired airway obstruction, and neurological insults. [8] [9] [10] This procedure appreciably shortens the duration of hospitalization among pediatric patients who need intensive respiratory care, 11 but may concurrently burden the caretakers greatly, even after the hospital discharge. Therefore, tracheostomy always presents a challenge to both the parents and neonatal care professionals. 12 The indication of tracheostomy may differently depend on the therapeutic strategies employed by a given NICU, the availability of surgical resources, ethical issues, and the economic status of the country in which the procedure is to be performed. Nevertheless, the number of patients who undergo tracheostomy is growing, and the surviving VLBWIs has been increasing in number as well as in proportion in developed countries. However, there are limited data available on the epidemiology and outcomes of tracheostomized VLBWIs. To combat this, the Neonatal Research Network of Japan (NRNJ) has prospectively registered and continued to collect clinical information of VLBWIs admitted to 204 NICUs in Japan since 2003. 1, 13 In the present study, to clarify the in-hospital NICU survival rates and morbidities associated with tracheostomy in VLBWIs, we investigated the clinical variables at birth and compared the outcomes between patients with and without tracheostomy using data from a nationwide cohort in Japan.
| MATERIALS AND METHODS

| Patient enrollment
A total of 40 806 VLBWIs were registered in the NRNJ database from 2003 to 2012. We excluded infants who died (n = 2375) or were discharged before 28 days of life (n = 1583), were transferred to unrecognized other hospitals (n = 1693), or gave no available data of tracheostomy (n = 481).
The study population ultimately consisted of 34 674 infants who did not meet the exclusion criteria and survived over 28 days of life ( Figure 1 ). This study was approved by the internal review board in Tokyo Women's Medical University, and registered as a prospective observational study with the University Hospital Medical Information Network clinical registration system in Japan (UMIN000006961). The data collection of all infants in the NRNJ was approved by the parents or guardians.
FIGURE 1
Flowchart of the selection of 324 patients who attained survival discharge from the hospital over 28 days after birth. Among all patients registered in the NRNJ database from 2003 to 2012, 6132 (15%) patients were excluded because of the death in NICU, transfer to other institutions, or no records on tracheostomy. The excluded infants had serious conditions at birth based on the comparative data between the included (n = 34 674) and the excluded (n = 6132) study populations, as shown in Table 1 2. Hypoxic-ischemic encephalopathy (HIE) was defined by clinical 19 and electro-encephalographic evidence 20 of acute brain injury due to asphyxia. Necrotizing enterocolitis was defined according to radiological or operative evidence and the criteria by Bell et al. 21 Retinopathy of prematurity (ROP) was treated by laser coagulation or cryocoagulation in accordance with the international classification. 22 Evidence of chromosomal abnormalities, congenital heart disease, central nervous system anomaly, and neuromuscular disease was assessed according to the 10th revision of the International
Statistical Classification of Diseases and Related Health Problems
(ICD-10) code.
| Statistical analyses
All statistical analyses were performed using the JMP® 11 software program (SAS Institute Inc., Cary, NC). Continuous and categorical variables were compared using Wilcoxon's rank sum test and the chisquared test, respectively. The prenatal and other clinical characteristics were examined further in terms of the risk for having subsequent tracheostomy using logistic regression analyses. These analyses included all aforementioned clinical factors except for post-neonatal death (after day 28 of life) and the duration of hospitalization. Results with P-values of <0.05 were considered to be statistically significant.
3 | RESULTS
| Clinical characteristics of the study population
The clinical characteristics of the 34 674 VLBWIs included in the study as well as those of the excluded infants are shown in Table S1 .
The median gestational age was 29.1 weeks and the median birth 
| Factors associated with tracheostomy
The clinical characteristics of the VLBWIs with and without tracheostomy were summarized in Table 1 
| Causes of death after 28 days of life
The rate of in-hospital mortality after 28 days of life did not differ between the tracheostomized and non-tracheostomized infants ( The proportion of tracheostomized VLBWIs in Japan was comparable to those in previous studies. 10, 23 We verified that the rate did not increase during the study period. Lee et al 24 As described in earlier studies, the optimum timing for tracheostomy has been a matter of discussion. 10, 23 Except for in emergencies, in Japan, tracheostomy is generally performed when the infant is over 1 month of age or the body weight is over 3 kg.
Little information on the age at tracheostomy was available in the NRNJ database. Because none of the infants who died before day 28 of life underwent tracheostomy in this study, the timing of tracheostomy was believed to be at ≥1 month of age. Our finding showed that neurological disease (HIE and muscular disease) and respiratory disease (BPD) were risk factors for tracheostomy. A previous study reported that the age at tracheostomy in patients with upper or lower airway problems was younger than in those with neurological diseases. 25 Furthermore, more than half of infants with airway obstruction, craniofacial anomalies, and cardiopulmonary disease underwent tracheostomy by 1 year of age. 26 The presence of neurological disease is associated with an inability to decannulate. 27 These findings imply that VLBWIs with HIE or muscular disease underwent tracheostomy later and were suspected of being more dependent on tracheostomy than those with BPD. However, because our database lacked information about anatomic airway disease, we are unable to discuss the rate of subglottic stenosis or tracheobronchomalacia. Further studies are therefore needed to determine when to offer such surgical procedures to patients with various airway problems.
The in-hospital mortality rate (0.6%) was markedly lower than those described in previous studies (14-44%). The pathogenesis of BPD has been known to be associated with both congenital and environmental factors. 28 Congenital factors include genetic susceptibility and fetal growth restriction, while environmental factors include mechanical ventilation, oxygen exposure, and nutritional deficits. Rare genetic variations may predispose
VLBWIs to the development of BPD with systemic complications. 29, 30 In this line, the comorbidity of BPD with neuromuscular dysfunctions may raise the common genetic base of neurological and respiratory development in some tracheostomized VLBWIs. .
The mortality of LBWIs with necrotizing enterocolitis remains high despite advances in the running of the NICU. 31 In this study, no tracheostomized VLBWIs died due to necrotizing enterocolitis (Table 2) , and relatively few tracheostomized VLBWIs received erythrocyte transfusion (Table S2) . VLBWIs with necrotizing enterocolitis are deemed to be in a severe condition and cannot undergo tracheostomy. The low odds ratio of necrotizing enterocolitis might indicate a selection bias for tracheostomy. Of note, several limitations associated with the present study warrant mention. First, we had little information on the timing or underlying disease for tracheostomies. Because there are no standardized criteria for tracheostomy in Japan, the performance of tracheostomy depends on the facilities or the status of the patient.
Second, we had no data on the mode by which patients were ventilated, although we found that 57 of 324 VLBWIs with tracheostomy needed ventilation. Some patients might have been weaned from ventilation using noninvasive positive-pressure ventilation or high-flow nasal cannula. Third, we lacked sufficient data on the mortality and neurodevelopmental outcomes after discharge from the NICU. Further analyses will require the collection of new data on the differences in the outcomes of tracheostomized VLBWIs based on varied long-term management approaches.
In conclusion, the first nationwide survey and our statistical analyses provided evidence of the efficacy of tracheostomy for NICU survivors in Japan. The comorbidity data indicate that preventive actions and regenerative measures to control the progression of BPD will further improve the long-term outcomes of VLBWIs requiring tracheostomy.
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